These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 11954954)

  • 1. Evaluation of arteriolar hyalinosis of the skin of patients with chronic congestive heart failure.
    Kishimoto C; Shioji K; Ito H; Kinoshita M; Lee JD; Shimizu H; Ueda T
    Circ J; 2002 Apr; 66(4):382-4. PubMed ID: 11954954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cutaneous arteriolar thioredoxin expression in patients with heart failure.
    Miyamoto M; Kishimoto C; Shioji K; Lee JD; Shimizu H; Ueda T; Yodoi J
    Circ J; 2003 Feb; 67(2):116-8. PubMed ID: 12547991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence of increased microvascular resistance and arteriolar hyalinosis in skin in congestive heart failure secondary to idiopathic dilated cardiomyopathy.
    Wroblewski H; Kastrup J; Nørgaard T; Mortensen SA; Haunsø S
    Am J Cardiol; 1992 Mar; 69(8):769-74. PubMed ID: 1372144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utility of B-type natriuretic peptide in differentiating congestive heart failure from lung disease in pediatric patients with respiratory distress.
    Koulouri S; Acherman RJ; Wong PC; Chan LS; Lewis AB
    Pediatr Cardiol; 2004; 25(4):341-6. PubMed ID: 15054559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kussmaul physiology in patients with heart failure.
    Nadir AM; Beadle R; Lim HS
    Circ Heart Fail; 2014 May; 7(3):440-7. PubMed ID: 24619369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of intravenous brain natriuretic peptide on regional sympathetic activity in patients with chronic heart failure as compared with healthy control subjects.
    Brunner-La Rocca HP; Kaye DM; Woods RL; Hastings J; Esler MD
    J Am Coll Cardiol; 2001 Apr; 37(5):1221-7. PubMed ID: 11300426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurohormonal and inflammatory markers as predictors of short-term outcome in patients with heart failure and cardiac resynchronization therapy.
    Glick A; Michowitz Y; Keren G; George J
    Isr Med Assoc J; 2006 Jun; 8(6):391-5. PubMed ID: 16833167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction.
    Tsutamoto T; Wada A; Maeda K; Hisanaga T; Maeda Y; Fukai D; Ohnishi M; Sugimoto Y; Kinoshita M
    Circulation; 1997 Jul; 96(2):509-16. PubMed ID: 9244219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different secretion patterns of atrial natriuretic peptide and brain natriuretic peptide in patients with congestive heart failure.
    Yoshimura M; Yasue H; Okumura K; Ogawa H; Jougasaki M; Mukoyama M; Nakao K; Imura H
    Circulation; 1993 Feb; 87(2):464-9. PubMed ID: 8425293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-terminal pro-b-type natriuretic peptide and left atrial function in patients with congestive heart failure and severely reduced ejection fraction.
    Prastaro M; Paolillo S; Savarese G; Dellegrottaglie S; Scala O; Ruggiero D; Gargiulo P; Marciano C; Parente A; Cecere M; Musella F; Chianese D; Scopacasa F; Perrone-Filardi P
    Eur J Echocardiogr; 2011 Jul; 12(7):506-13. PubMed ID: 21685193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood volume and brain natriuretic peptide in congestive heart failure: a pilot study.
    James KB; Troughton RW; Feldschuh J; Soltis D; Thomas D; Fouad-Tarazi F
    Am Heart J; 2005 Nov; 150(5):984. PubMed ID: 16290978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of hyperadiponectinemia with severity of ventricular dysfunction in congestive heart failure.
    Nakamura T; Funayama H; Kubo N; Yasu T; Kawakami M; Saito M; Momomura S; Ishikawa SE
    Circ J; 2006 Dec; 70(12):1557-62. PubMed ID: 17127799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High levels of plasma brain natriuretic peptide and interleukin-6 after optimized treatment for heart failure are independent risk factors for morbidity and mortality in patients with congestive heart failure.
    Maeda K; Tsutamoto T; Wada A; Mabuchi N; Hayashi M; Tsutsui T; Ohnishi M; Sawaki M; Fujii M; Matsumoto T; Kinoshita M
    J Am Coll Cardiol; 2000 Nov; 36(5):1587-93. PubMed ID: 11079662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of digoxin on atrial natriuretic peptide (ANP), brain natriuretic peptide (BNP) and cyclic 3', 5'-guanosine monophosphate (cGMP) in patients with chronic congestive heart failure].
    Kobusiak-Prokopowicz M; Swidnicka-Szuszkowska B; Mysiak A
    Pol Arch Med Wewn; 2001 Jun; 105(6):475-82. PubMed ID: 11865578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bedside B-Type natriuretic peptide in the emergency diagnosis of heart failure with reduced or preserved ejection fraction. Results from the Breathing Not Properly Multinational Study.
    Maisel AS; McCord J; Nowak RM; Hollander JE; Wu AH; Duc P; Omland T; Storrow AB; Krishnaswamy P; Abraham WT; Clopton P; Steg G; Aumont MC; Westheim A; Knudsen CW; Perez A; Kamin R; Kazanegra R; Herrmann HC; McCullough PA;
    J Am Coll Cardiol; 2003 Jun; 41(11):2010-7. PubMed ID: 12798574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cut-off values of B-type natriuretic peptide for the diagnosis of congestive heart failure in patients with dyspnoea visiting emergency departments: a study on Korean patients visiting emergency departments.
    Choi S; Park D; Lee S; Hong Y; Kim S; Lee J
    Emerg Med J; 2007 May; 24(5):343-7. PubMed ID: 17452702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myocardial production of C-type natriuretic peptide in chronic heart failure.
    Kalra PR; Clague JR; Bolger AP; Anker SD; Poole-Wilson PA; Struthers AD; Coats AJ
    Circulation; 2003 Feb; 107(4):571-3. PubMed ID: 12566368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Plasma levels of brain natriuretic peptide, cyclic 3'5'-guanosine monophosphate, endothelin 1, and noradrenaline in patients with chronic congestive heart failure].
    Salomon P; Przewłocka-Kosmala M; Orda A
    Pol Arch Med Wewn; 2003 Jan; 109(1):43-8. PubMed ID: 12879765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of body mass index on natriuretic peptide levels in patients with acute congestive heart failure: a ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) substudy.
    Krauser DG; Lloyd-Jones DM; Chae CU; Cameron R; Anwaruddin S; Baggish AL; Chen A; Tung R; Januzzi JL
    Am Heart J; 2005 Apr; 149(4):744-50. PubMed ID: 15990762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemodynamic, renal, and hormonal responses to brain natriuretic peptide infusion in patients with congestive heart failure.
    Yoshimura M; Yasue H; Morita E; Sakaino N; Jougasaki M; Kurose M; Mukoyama M; Saito Y; Nakao K; Imura H
    Circulation; 1991 Oct; 84(4):1581-8. PubMed ID: 1914098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.